BRAF and neoplasm: Clinical features (e.g., disease stage, tumor grade, histology, location), demographic variables (e.g., age at diagnosis, sex, and familial risk status), and tumor characteristics (e.g., the MSI tumor phenotype and somatic mutations, including BRAF Val600Glu mutation) are among the most commonly investigated variables in colorectal cancer [5–10].